You are here: All Products  > China Approves Merck's Keytruda, a PD-1 Drug, for First Line NSCLC

China Approves Merck's Keytruda, a PD-1 Drug, for First Line NSCLC

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products